Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis
about
Promising new treatments for psoriasisInositol lipids: from an archaeal origin to phosphatidylinositol 3,5-bisphosphate faults in human diseaseReview: The interleukin-23/interleukin-17 axis in spondyloarthritis pathogenesis: Th17 and beyondPIKfyve, a class III PI kinase, is the target of the small molecular IL-12/IL-23 inhibitor apilimod and a player in Toll-like receptor signalingThe phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infectionThe dark side of dendritic cells: development and exploitation of tolerogenic activity that favor tumor outgrowth and immune escape.Inhibition of PIKfyve prevents myocardial apoptosis and hypertrophy through activation of SIRT3 in obese mice.Toll-like receptor 9 trafficking and signaling for type I interferons requires PIKfyve activityLangerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice.The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses.Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells.Role of IL-23 in the pathogenesis of psoriasis: a novel potential therapeutic target?The IL-17-Th1/Th17 pathway: an attractive target for lung cancer therapy?IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer.Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma.
P2860
Q24598008-00294DDA-A65F-4704-A969-3FDE608027DCQ26852772-9766CA10-2E87-4CCD-8612-3FEA1C469429Q26991709-C00995E3-2E91-431B-8C09-8F3C13E91D92Q28833590-6B43F75F-E324-4495-A24D-56B033FF4B28Q30252649-D7A8BBBE-EE57-41ED-A3D2-0C2CB35BA186Q30317628-E5933762-F31A-4A88-8C1C-F2BAA8008E62Q33749025-16B03098-3613-40D7-ACED-5A4BB98F42ADQ36027805-222021DF-B1C2-459E-94E9-6E57AA392B39Q36967801-813B6BE2-36A6-45AB-8102-13EBA90B7483Q37040371-BDDE96D4-88AF-4F11-8E60-FCD1AC94CCB4Q37689058-F6B974A8-EEE7-4691-93E2-D9D5E82179D5Q38190986-1AB44E37-4E1F-4EF5-AB3C-FF8C110E7258Q38879975-AD9F44D0-365F-488E-9AF4-EFA29C149370Q42164215-A410CE7C-029B-41BE-9999-EA9E0942C966Q50192754-DDA842A5-E2BF-48E7-893C-CC0C9F59C514
P2860
Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@ast
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@en
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@nl
type
label
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@ast
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@en
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@nl
prefLabel
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@ast
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@en
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@nl
P2093
P2860
P1433
P1476
Apilimod inhibits the producti ...... cell infiltration in psoriasis
@en
P2093
Aaron B Kantor
Alice B Gottlieb
Artemis Khatcherian
Eric Jacobson
Irma Cardinale
James Barsoum
James G Krueger
Noriaki Tatsuta
Yumiko Wada
P2860
P304
P356
10.1371/JOURNAL.PONE.0035069
P407
P577
2012-01-01T00:00:00Z